Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary
We appreciate the comments made by Dr Bedel and colleagues. NLR, PLR and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Because of this, we have listed some of the above-mentioned disorders in the tables. Hematological di...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021-08-01
|
| Series: | Biomolecules & Biomedicine |
| Subjects: | |
| Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292 |
| _version_ | 1827317482230120448 |
|---|---|
| author | Nuri Kose Tarık Yıldırım Fatih Akın Seda Elçim Yıldırım Ibrahim Altun |
| author_facet | Nuri Kose Tarık Yıldırım Fatih Akın Seda Elçim Yıldırım Ibrahim Altun |
| author_sort | Nuri Kose |
| collection | DOAJ |
| description |
We appreciate the comments made by Dr Bedel and colleagues. NLR, PLR and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Because of this, we have listed some of the above-mentioned disorders in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were therefore excluded from the study. However, the presence of malignancy did not affect our results in regression analysis.
Platelets swell until 120 minutes in ethylene diamine tetra acetic (EDTA) and until 60 minutes in citrate [2]. Authors suggest that optimal measuring time should not exceed 120 minutes. The blood samples of the patients were taken within 1 hour after their emergency admission. All blood samples in our study were tested within 1 hour of collection [3]. We used EDTA for whole blood anticoagulation. The mean duration of symptoms prior to admission was 5.04 ± 6.9 days.
The drugs such as corticosteroids affect inflammatory parameters. Therefore, we excluded inflammatory diseases without emphasizing corticosteroids or other anti-inflammatory drugs.
|
| first_indexed | 2024-04-24T23:39:34Z |
| format | Article |
| id | doaj.art-e6f42f37d88e42ac89b6188829c9c24b |
| institution | Directory Open Access Journal |
| issn | 2831-0896 2831-090X |
| language | English |
| last_indexed | 2024-04-24T23:39:34Z |
| publishDate | 2021-08-01 |
| publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
| record_format | Article |
| series | Biomolecules & Biomedicine |
| spelling | doaj.art-e6f42f37d88e42ac89b6188829c9c24b2024-03-15T13:44:08ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2021-08-0121410.17305/bjbms.2020.5292Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentaryNuri Kose0https://orcid.org/0000-0001-8658-2598Tarık Yıldırım1Fatih Akın2Seda Elçim Yıldırım3Ibrahim Altun4Private Yuvelen HospitalDepartment of Cardiology, Faculty of Medicine, Balikesir University, Balikesir, TurkeyDepartment of Cardiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, TurkeyDepartment of Cardiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, TurkeyDepartment of Cardiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey We appreciate the comments made by Dr Bedel and colleagues. NLR, PLR and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Because of this, we have listed some of the above-mentioned disorders in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were therefore excluded from the study. However, the presence of malignancy did not affect our results in regression analysis. Platelets swell until 120 minutes in ethylene diamine tetra acetic (EDTA) and until 60 minutes in citrate [2]. Authors suggest that optimal measuring time should not exceed 120 minutes. The blood samples of the patients were taken within 1 hour after their emergency admission. All blood samples in our study were tested within 1 hour of collection [3]. We used EDTA for whole blood anticoagulation. The mean duration of symptoms prior to admission was 5.04 ± 6.9 days. The drugs such as corticosteroids affect inflammatory parameters. Therefore, we excluded inflammatory diseases without emphasizing corticosteroids or other anti-inflammatory drugs. https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292neutrophil-lymphocyte-ratioplatelet-lymphocyte-ratiomonocyte-lymphocyte-ratioNLRPLRMLR |
| spellingShingle | Nuri Kose Tarık Yıldırım Fatih Akın Seda Elçim Yıldırım Ibrahim Altun Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary Biomolecules & Biomedicine neutrophil-lymphocyte-ratio platelet-lymphocyte-ratio monocyte-lymphocyte-ratio NLR PLR MLR |
| title | Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary |
| title_full | Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary |
| title_fullStr | Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary |
| title_full_unstemmed | Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary |
| title_short | Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary |
| title_sort | can nlr plr and lmr be used as prognostic indicators in patients with pulmonary embolism author s reply on commentary |
| topic | neutrophil-lymphocyte-ratio platelet-lymphocyte-ratio monocyte-lymphocyte-ratio NLR PLR MLR |
| url | https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292 |
| work_keys_str_mv | AT nurikose cannlrplrandlmrbeusedasprognosticindicatorsinpatientswithpulmonaryembolismauthorsreplyoncommentary AT tarıkyıldırım cannlrplrandlmrbeusedasprognosticindicatorsinpatientswithpulmonaryembolismauthorsreplyoncommentary AT fatihakın cannlrplrandlmrbeusedasprognosticindicatorsinpatientswithpulmonaryembolismauthorsreplyoncommentary AT sedaelcimyıldırım cannlrplrandlmrbeusedasprognosticindicatorsinpatientswithpulmonaryembolismauthorsreplyoncommentary AT ibrahimaltun cannlrplrandlmrbeusedasprognosticindicatorsinpatientswithpulmonaryembolismauthorsreplyoncommentary |